Safety and Efficacy of NABOTA in Treatment of Essential Blepharospasm
Clinical trial NCT02947815 · COMPLETED
Trial details
- NCT number
- NCT02947815
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-01
- Primary completion
- 2018-01-01
- Enrollment
- 234
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.